Blood. 8 February 2024: Tao Dao, Guangyan Xiong, Sung Soo Mun, Jeremy Meyerberg, Tatyana Korontsvit, Jingyi Xiang, Ziyou Cui , Aaron Y Chang, Casey Jarvis, Winson Cai, Hanzhi Luo, Aspen Pierson, Anthony Daniyan, Sarah Yoo, Sumiko Takao, Michael Kharas, Alex Kentsis, Cheng Liu, David A Scheinberg
Journal of Hematology & Oncology. 21 January 2023: Chenggong Li, Fen Zhou, Jing Wang, Qi Chang, Mengyi Du, Wenjing Luo, Yinqiang Zhang, Jia Xu, Lu Tang, Huiwen Jiang, Lin Liu, Haiming Kou, Cong Lu, Danying Liao, Jianghua Wu, Qiuzhe Wei, Sha Ke, Jun Deng, Cheng Liu, Heng Mei & Yu Hu
Scientific Reports. 15 July 2022: Chang Liu, Hong Liu, Moumita Dasgupta, Lance M. Hellman, Xiaogang Zhang, Kai Qu, Hui Xue, Yun Wang, Fenling Fan, Qi Chang, Duo Yu, Linhu Ge, Yu Zhang, Ziyou Cui, Pengbo Zhang, Bradley Heller, Hongbing Zhang, Bingyin Shi, Brian M. Baker & Cheng Liu
Journal of Cancer Research and Clinical Oncology. 1 July 2022: Pengcheng He, Haibo Liu , Bryan Zimdahl, Jie Wang, Minna Luo, Qi Chang, Fangzhou Tian, Fan Ni, Duo Yu, Huasheng Liu, Limei Chen, Huaiyu Wang, Mei Zhang, Stephan A Grupp, Cheng Liu
Blood. April 15 2022: Martin G Klatt, Tao Dao, Zhiyuan Yang, Jianying Liu, Sung Soo Mun, Megan M Dacek, Hanzhi Luo, Thomas J Gardner, Christopher M Bourne, Leila Peraro, Zita E H Aretz, Tanya Korontsvit, Michael Lau, Michael Gregory Kharas, Cheng Liu, David A Scheinberg
Frontiers in Immunology. 14 April 2021: Oladapo O. Yeku, Thapi Dharma Rao, Ian Laster, Artem Kononenko, Terence J. Purdon, Pei Wang, Ziyou Cui, Hong Liu, Renier J. Brentjens and David Spriggs
Journal OncoImmunology. 15 April 2019: Tao Dao, Sung Soo Mun, Andrew C. Scott, Casey A. Jarvis, Tatyana Korontsvit, Zhiyuan Yang, Lianxing Liu, Martin G. Klatt, Manuel Guerreiro, Annamalai Selvakumar, Elliott J. Brea, Claire Oh, Cheng Liu & David A. Scheinberg
Science Translational Medicine. 27 March 2019: E L Smith, K Harrington, M Staehr, R Masakayan, J Jones, T J Long, K Y Ng, M Ghoddusi, T J Purdon, X Wang, T Do, M T Pham, J M Brown, C F De Larrea, E Olson, E Peguero, P Wang, H Liu, Y Xu, S C Garrett-Thomson, S C Almo, H-G Wendel, I Riviere, C Liu, B Sather & R J Brentjens
Cell Discovery. 20 November 2018: Yiyang Xu, Zhiyuan Yang, Lucas H. Horan, Pengbo Zhang, Lianxing Liu, Bryan Zimdahl, Shon Green, Jingwei Lu, Javier F. Morales, David M. Barrett, Stephan A. Grupp, Vivien W. Chan, Hong Liu & Cheng Liu
Nature Biotechnology. 1 October 2018: Sarwish Rafiq, Oladapo O Yeku, Hollie J Jackson, Terence J Purdon, Dayenne G van Leeuwen, Dylan J Drakes, Mei Song, Matthew M Miele, Zhuoning Li, Pei Wang, Su Yan, Jingyi Xiang, Xiaojing Ma, Venkatraman E Seshan, Ronald C Hendrickson, Cheng Liu & Renier J Brentjens
Alexa Willson has served as the Chief Financial Officer of Eureka Therapeutics since August 2022. Prior to joining the company, She was a Managing Partner of Cloudstone Venture Capital, an early-stage healthtech venture firm since October 2020. Cloudstone is also an investor of Eureka Therapeutics.
Ms. Willson has over 25 years of experience advising public and private companies on corporate finance, strategy, capital raising, valuation, mergers & acquisitions, and other matters. She has founded and run a midmarket investment banking boutique and worked with large Wall Street investment banks, including Kidder Peabody and Drexel Burnham.
Ms. Willson has served on private and non-profit boards and investment committees in various capacities. She teaches financial literacy. Ms. Willson holds a BA from Harvard and an MBA from Stanford Graduate School of Business.